Barclays analyst Mario Lu maintains Unity Software (NYSE:U) with a Equal-Weight and raises the price target from $35 to $49.
Sage Therapeutics Q4 EPS $(2.47) Misses $(2.39) Estimate, Sales $2.87M Beat $1.94M Estimate
Sage Therapeutics (NASDAQ:SAGE) reported quarterly losses of $(2.47) per share which missed the analyst consensus estimate of $(2.39) by 3.35 percent. This is a 16.51 percent decrease over losses of $(2.12) per share
